BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Staging
835 results:

  • 1. Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer - the SENTRY clinical trial.
    Sorokin P; Novozhilov M; Utkin D; Abduragimova Z; Dudina I; Nikiforchin A; Kulikova S
    Klin Onkol; 2024; 38(2):126-133. PubMed ID: 38697821
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
    Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
    BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 4. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
    Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
    Int J Gynecol Cancer; 2024 May; 34(5):697-704. PubMed ID: 38508587
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sentinel Node Mapping in ovarian Tumors: A Study Using Lymphoscintigraphy and SPECT/CT.
    Ataei Nakhaei S; Sadeghi R; Mostafavi SM; Treglia G; Hassanzadeh M; Esmaeilpour M; Taheri NS; Farazestanian M
    Contrast Media Mol Imaging; 2024; 2024():5453692. PubMed ID: 38435483
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
    Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
    World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The significance of lower uterine segment involvement in endometrial cancer.
    Davidesko S; Meirovitz M; Shaco-Levy R; Yarza S; Samueli B; Kezerle Y; Kessous R
    Eur J Surg Oncol; 2024 Mar; 50(3):108007. PubMed ID: 38382274
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
    Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
    Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.
    Jassar A; Hemali N; Bhatnagar A
    Indian J Pathol Microbiol; 2024; 67(1):68-73. PubMed ID: 38358191
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
    Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
    Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Katsanevakis E; Addo-Yobo W; Bharathan B; Loona A; Gan C; Nunns D; Gajjar K
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():105-110. PubMed ID: 38237307
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.
    Chandy RG; Thomas V; Sebastian A; Mani T; Thomas A; Joel A; Ram TS; Peedicayil A
    Indian J Cancer; 2023 Oct; 60(4):475-485. PubMed ID: 38185864
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study.
    Shim SH; Lim J; Kim JH; Lee YJ; Ha HI; Lim MC; Won YJ
    J Gynecol Oncol; 2024 May; 35(3):e32. PubMed ID: 38130136
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
    Vasta FM; Cormio G; Cassani C; Bergamini A; Scarfone G; Ferrandina G; De Vivo R; Marinaccio M; Danese S; Raspagliesi F; Pignata S; Mangili G
    Gynecol Oncol; 2024 Feb; 181():28-32. PubMed ID: 38104526
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY).
    Nero C; Bizzarri N; Di Berardino S; Sillano F; Vizzielli G; Cosentino F; Vargiu V; De Iaco P; Perrone AM; Vizza E; Chiofalo B; Uccella S; Ghezzi F; Turco LC; Corrado G; Giannarelli D; Pasciuto T; Zannoni GF; Fagotti A; Scambia G
    Eur J Cancer; 2024 Jan; 196():113435. PubMed ID: 38006759
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
    Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
    Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
    Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
    Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation.
    Ghanem AI; Bhatnagar A; Elshaikh M; Hijaz M; Elshaikh MA
    Am J Clin Oncol; 2023 Dec; 46(12):537-542. PubMed ID: 37679878
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary.
    Mazina V; Devins K; Philp L; Bercow AS; James K; Bregar A; Sisodia RC; Oliva E; Del Carmen M
    Int J Gynecol Cancer; 2023 Sep; 33(9):1434-1439. PubMed ID: 37567599
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 42.